Hetero Labs Limited FDA Inspection Record

FEI 3008307735 · Inspections, Form 483s, warning letters and import refusals

Hetero Labs Limited is an FDA-registered facility (FEI 3008307735) located in Mahabubnagar, IN. Registered operations: MANUFACTURE. RegDataLab tracks 5 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Aug 12, 2022: Voluntary Action Indicated (VAI)
Inspections on record
5 (1 OAI, 2 VAI, 2 NAI)
Last OAI inspection
Dec 16, 2016
Warning letters
1 listed by FDA for this FEI, latest Aug 15, 2017
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
7, latest Mar 26, 2026
Import refusals
4

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 12, 2022Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Training , Education , Experience overall (21 CFR 211.25(a))
Written procedures not established/followed (21 CFR 211.67(b))
Computer control of master formula records (21 CFR 211.68(b))
and 2 more
Dec 16, 2016Official Action Indicated (OAI)No citations listed
May 1, 2015No Action Indicated (NAI)No citations listed
May 24, 2013Voluntary Action Indicated (VAI)No citations listed
Nov 19, 2010No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 26, 2026Class IID-0484-2026Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only…
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Aug 6, 2020Class IID-1545-2020Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber…
Failed Tablet/Capsule Specification; complaint of bulging tablet
Aug 20, 2018Class IID-1213-2018Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs…
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Aug 15, 2018Class ID-0081-2019Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs…
Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.
Aug 8, 2018Class IID-1113-2018Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 40 mg, 30 Tablets Rx Only… and 3 more products
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Feb 13, 2018Class IID-0601-2018Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber… and 1 more product
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or…
Dec 22, 2017Class IID-0415-2018Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber…
Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged…

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Dec 16, 2016, which is not always the inspection or issue date. Published by FDA Jan 13, 2017.

FDA record score

31 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

11 records behind this number
RecordDatePoints x age weightAdds
Warning letter on FDA's dashboard, which does not show close-outsAug 15, 201730 x 0.257.5
Inspection classified OAIDec 16, 201630 x 0.257.5
Class II recall D-0484-2026, this FEI as the recalling firmMar 26, 20264 x 14
Class I recall D-0081-2019, this FEI as the recalling firmAug 15, 201815 x 0.253.8
Inspection classified VAIAug 12, 20226 x 0.63.6
Class II recall D-1545-2020, this FEI as the recalling firmAug 6, 20204 x 0.251
Class II recall D-1213-2018, this FEI as the recalling firmAug 20, 20184 x 0.251
Class II recall D-1113-2018, this FEI as the recalling firmAug 8, 20184 x 0.251
Class II recall D-0601-2018, this FEI as the recalling firmFeb 13, 20184 x 0.251
Class II recall D-0415-2018, this FEI as the recalling firmDec 22, 20174 x 0.251
Inspection classified VAIMay 24, 201310 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Hetero Labs Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Hetero Labs Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Hetero Labs Limited (Unit V)
Location
Mahabubnagar (IN)
Registration Expires
Dec 31, 2027
Operations
MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.